News

The hospital germ Pseudomonas aeruginosa forms biofilms, a kind of mucus layer, to protect itself from attack by the immune system or antibiotics. To form this sticky layer, as well as to successfully

With INCATE (INCubator for Antibacterial Therapies in Europe), the German Center for Infection Research (DZIF) has participated in the foundation of a European initiative to take up the fight against

Hepatitis B virus (HBV) infections remain a major global health problem – according to the World Health Organization (WHO) there are around 300 million HBV carriers worldwide. Current treatments

The 2022 Prize for Translational Infection Research of the German Center for Infection Research (DZIF), endowed with 5,000 euros, goes to the DZIF scientist and epidemiologist Gérard Krause. Prof

How widespread is the pathogenic gastric bacterium Helicobacter pylori in the German population? In the study "Helicobacter pylori prevalence, therapy success, resistance" (HelicoPTER), for which

The prevention and treatment of human immunodeficiency virus (HIV) infections has made great strides in recent years. At the same time, however, new challenges are emerging, for example in connection

The Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR) in Ghana is celebrating its 25th anniversary and its successful infection research with a ceremony and a scientific symposium

Dr. Victoria Ingham, a scientist at Heidelberg Medical Faculty and the German Center for Infection Research (DZIF), has been awarded an ERC Starting Grant of 1.5 million euro for her research on the

Stephan Urban, DZIF professor at Heidelberg University Hospital, receives the Baruch S. Blumberg Prize 2023 from the Hepatitis B Foundation, a global non-profit organisation. The virologist is being

This year‘s Science Award of the German Stifterverband ‚Research with Responsibility‘ goes to Jörg Overmann, Scientific Director of the Leibniz Institute DSMZ-German Collection of Microorganisms and